Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
CXSL2300420	IBI310	ipilimumab	Injection	Biological Products(2.2)	New Drug Application	2023-06-19		Innovent Biologics (Suzhou) Co Ltd			view
CXSL2101073	IBI310	ipilimumab	Injection	Biological Products(2.2)	New Drug Application	2021-05-14		Innovent Biologics (Suzhou) Co Ltd			view
CXSL2000233	IBI310	ipilimumab	Injection	Biological Products(3.3)	New Drug Application	2020-08-12	信达生物制药（苏州）有限公司	Innovent Biologics (Suzhou) Co Ltd	In Review	2020-08-11	view
CXSL2000231	IBI310	ipilimumab	Injection	Biological Products(3.3)	New Drug Application	2020-08-12	信达生物制药（苏州）有限公司	Innovent Biologics (Suzhou) Co Ltd	In Review	2020-08-11	view
CXSL2000222	IBI310	ipilimumab	Injection	Biological Products(3.3)	New Drug Application	2020-08-04	信达生物制药（苏州）有限公司	Innovent Biologics (Suzhou) Co Ltd	In Review	2020-08-03	view